{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:28:30Z","timestamp":1790310510421,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.109910","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T11:04:13Z","timestamp":1678446253000},"page":"109910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Dexmedetomidine alleviates oxidative stress and mitochondrial dysfunction in diabetic peripheral neuropathy via the microRNA-34a\/SIRT2\/S1PR1 axis"],"prefix":"10.1016","volume":"117","author":[{"given":"Ying","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3445-7354","authenticated-orcid":false,"given":"Yanzhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S01","key":"10.1016\/j.intimp.2023.109910_b0005","first-page":"S1","article-title":"Definition, classification and diagnosis of diabetes mellitus","volume":"127","author":"Petersmann","year":"2019","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"1","key":"10.1016\/j.intimp.2023.109910_b0010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/ATVBAHA.117.310221","article-title":"Highlighting diabetes mellitus: the epidemic continues","volume":"38","author":"Schmidt","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109910_b0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109910_b0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12916-017-0901-x","article-title":"Environmental\/lifestyle factors in the pathogenesis and prevention of type 2 diabetes","volume":"15","author":"Kolb","year":"2017","journal-title":"BMC Med."},{"issue":"7","key":"10.1016\/j.intimp.2023.109910_b0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"12","key":"10.1016\/j.intimp.2023.109910_b0030","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S2213-8587(19)30081-6","article-title":"Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention","volume":"7","author":"Selvarajah","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109910_b0035","doi-asserted-by":"crossref","first-page":"e0212574","DOI":"10.1371\/journal.pone.0212574","article-title":"The risk factors for diabetic peripheral neuropathy: a meta-analysis","volume":"14","author":"Liu","year":"2019","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.intimp.2023.109910_b0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0039-1688978","article-title":"Diabetic neuropathy","volume":"39","author":"Zakin","year":"2019","journal-title":"Semin. Neurol."},{"issue":"10","key":"10.1016\/j.intimp.2023.109910_b0045","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40265-015-0419-5","article-title":"Dexmedetomidine: a review of its use for sedation in the intensive care setting","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2023.109910_b0050","doi-asserted-by":"crossref","first-page":"4035310","DOI":"10.1155\/2018\/4035310","article-title":"Dexmedetomidine ameliorates acute stress-induced kidney injury by attenuating oxidative stress and apoptosis through inhibition of the ROS\/JNK signaling pathway","volume":"2018","author":"Chen","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.intimp.2023.109910_b0055","first-page":"370","article-title":"Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K\/Akt pathway","volume":"23","author":"Liang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2023.109910_b0060","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bbi.2020.10.008","article-title":"Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central alpha2A adrenoceptor","volume":"91","author":"Mei","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.intimp.2023.109910_b0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41419-019-1416-5","article-title":"Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2023.109910_b0070","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3389\/fphar.2020.01139","article-title":"The protective effect and mechanism of dexmedetomidine on diabetic peripheral neuropathy in rats","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109910_b0075","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109910_b0080","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2023.109910_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113694","article-title":"Treatment of diabetic peripheral neuropathy with engineered mesenchymal stromal cell-derived exosomes enriched with microRNA-146a provide amplified therapeutic efficacy","volume":"341","author":"Fan","year":"2021","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109910_b0090","doi-asserted-by":"crossref","first-page":"623","DOI":"10.17219\/acem\/131217","article-title":"Investigation of the role of miR-221 in diabetic peripheral neuropathy and related molecular mechanisms","volume":"30","author":"Wu","year":"2021","journal-title":"Adv. Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.109910_b0095","first-page":"587","article-title":"miR-590-3p Alleviates diabetic peripheral neuropathic pain by targeting RAP1A and suppressing infiltration by the T cells","volume":"67","author":"Wu","year":"2020","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.intimp.2023.109910_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153749","article-title":"Astragaloside IV alleviates Schwann cell injury in diabetic peripheral neuropathy by regulating microRNA-155-mediated autophagy","volume":"92","author":"Yin","year":"2021","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.intimp.2023.109910_b0105","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1007\/s12035-018-1047-3","article-title":"MiR-34a regulates axonal growth of dorsal root ganglia neurons by targeting FOXP2 and VAT1 in postnatal and adult mouse","volume":"55","author":"Jia","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2023.109910_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117359","article-title":"Dexmedetomidine improves propofol-induced neuronal injury in rat hippocampus with the involvement of miR-34a and the PI3K\/Akt signaling pathway","volume":"247","author":"Xing","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.109910_b0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12974-022-02462-6","article-title":"An RNA-sequencing transcriptome of the rodent Schwann cell response to peripheral nerve injury","volume":"19","author":"Brosius Lutz","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.intimp.2023.109910_b0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrneurol.2016.201","article-title":"Schwann cell interactions with axons and microvessels in diabetic neuropathy","volume":"13","author":"Goncalves","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.intimp.2023.109910_b0125","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41419-021-03930-2","article-title":"TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K\/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.intimp.2023.109910_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/cells9091948","article-title":"Loganin attenuates high glucose-induced Schwann cells pyroptosis by inhibiting ROS generation and NLRP3 inflammasome activation","volume":"9","author":"Cheng","year":"2020","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.intimp.2023.109910_b0135","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1096\/fj.201900127R","article-title":"STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy","volume":"33","author":"Du","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2023.109910_b0140","article-title":"Quercetin attenuates diabetic peripheral neuropathy by correcting mitochondrial abnormality via activation of AMPK\/PGC-1alpha pathway in vivo and in vitro","volume":"15","author":"Zhang","year":"2021","journal-title":"Front. Neurosci."},{"issue":"11","key":"10.1016\/j.intimp.2023.109910_b0145","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1373\/clinchem.2008.113126","article-title":"TaqMan-based real-time PCR for genotyping common polymorphisms of haptoglobin (HP1 and HP2)","volume":"54","author":"Soejima","year":"2008","journal-title":"Clin. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2023.109910_b0150","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/10715760701435228","article-title":"Oxidative stress in childhood type 1 diabetes: results from a study covering the first 20 years of evolution","volume":"41","author":"Martin-Gallan","year":"2007","journal-title":"Free Radic. Res."},{"issue":"6","key":"10.1016\/j.intimp.2023.109910_b0155","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.clinthera.2018.04.001","article-title":"Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy","volume":"40","author":"Iqbal","year":"2018","journal-title":"Clin. Ther."},{"issue":"7","key":"10.1016\/j.intimp.2023.109910_b0160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/jphp.13241","article-title":"Treatment of diabetic peripheral neuropathy: a review","volume":"72","author":"Khdour","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2023.109910_b0165","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1248\/bpb.b17-00224","article-title":"The therapeutic effect of dexmedetomidine on rat diabetic neuropathy pain and the mechanism","volume":"40","author":"Lu","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.intimp.2023.109910_b0170","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2017.07.048","article-title":"Systemic dexmedetomidine attenuates mechanical allodynia through extracellular sign db type 2 diabetic mice","volume":"657","author":"Chen","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.intimp.2023.109910_b0175","doi-asserted-by":"crossref","first-page":"e201901105","DOI":"10.1590\/s0102-865020190110000005","article-title":"Dexmedetomidine attenuates P2X4 and NLRP3 expression in the spine of rats with diabetic neuropathic pain","volume":"34","author":"Kang","year":"2019","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.intimp.2023.109910_b0180","doi-asserted-by":"crossref","first-page":"9043628","DOI":"10.1155\/2018\/9043628","article-title":"Dexmedetomidine reduces diabetic neuropathy pain in rats through the Wnt 10a\/beta-catenin signaling pathway","volume":"2018","author":"Zhong","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"6","key":"10.1016\/j.intimp.2023.109910_b0185","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200394","article-title":"Dexmedetomidine exerts neuroprotective effects during high glucose-induced neural injury by inhibiting miR-125b","volume":"40","author":"Hou","year":"2020","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2023.109910_b0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12031-018-1231-y","article-title":"miR-34a in neurophysiology and neuropathology","volume":"67","author":"Chua","year":"2019","journal-title":"J. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.intimp.2023.109910_b0195","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.3892\/mmr.2015.4185","article-title":"MicroRNA34a induces apoptosis in PC12 cells by reducing Bcell lymphoma 2 and sirtuin1 expression","volume":"12","author":"Lin","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"17","key":"10.1016\/j.intimp.2023.109910_b0200","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/WNR.0000000000001539","article-title":"MiR-34a regulates Schwann cell proliferation and migration by targeting CNTN2","volume":"31","author":"Zou","year":"2020","journal-title":"Neuroreport"},{"key":"10.1016\/j.intimp.2023.109910_b0205","article-title":"SIRT1 and SIRT2 activity control in neurodegenerative diseases","volume":"11","author":"Manjula","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109910_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100961","article-title":"SIRT2: controversy and multiple roles in disease and physiology","volume":"55","author":"Wang","year":"2019","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2023.109910_b0215","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s13311-020-00860-3","article-title":"SIRT2 inhibition improves functional motor recovery after peripheral nerve injury","volume":"17","author":"Romeo-Guitart","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.intimp.2023.109910_b0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.expneurol.2018.08.001","article-title":"High glucose concentration suppresses a SIRT2 regulated pathway that enhances neurite outgrowth in cultured adult sensory neurons","volume":"309","author":"Schartner","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2023.109910_b0225","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mcn.2018.05.006","article-title":"Depressed mitochondrial function and electron transport Complex II-mediated H2O2 production in the cortex of type 1 diabetic rodents","volume":"90","author":"Roy Chowdhury","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2023.109910_b0230","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10753-017-0713-3","article-title":"Overexpression of SIRT2 alleviates neuropathic pain and neuroinflammation through deacetylation of transcription factor nuclear factor-kappa B","volume":"41","author":"Zhang","year":"2018","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.intimp.2023.109910_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22030344","article-title":"Sphingosine 1-phosphate receptor 1 signaling in mammalian cells","volume":"22","author":"Pyne","year":"2017","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.intimp.2023.109910_b0240","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/cpt.1958","article-title":"Genomewide meta-analysis validates a role for S1PR1 in microtubule targeting agent-induced sensory peripheral neuropathy","volume":"108","author":"Chua","year":"2020","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:57:33Z","timestamp":1761587853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923002308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":48,"alternative-id":["S1567576923002308"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109910","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dexmedetomidine alleviates oxidative stress and mitochondrial dysfunction in diabetic peripheral neuropathy via the microRNA-34a\/SIRT2\/S1PR1 axis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109910"}}